Givinostat

Chemical formula: C₂₄H₂₇N₃O₄  Molecular mass: 421.2 g/mol  PubChem compound: 9804992

Therapeutic indications

Givinostat is indicated for:

Duchenne muscular dystrophy

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Givinostat is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Givinostat is contraindicated in the following cases:

Platelet count <150 x 10⁹/L

Platelet count below reference range

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2024: DUVYZAT Oral suspension
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈